Close Menu

NEW YORK – Enzo Biochem reported after the close of the markets on Tuesday that its fiscal first quarter 2020 revenues fell 5 percent year over year, largely due to a decline in clinical services revenues.

For the three months ended Oct. 31, 2019, the company reported total revenues of $20.2 million, down from $21.3 million in the year-ago period.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Master's and doctoral students in the UK call on funding groups to extend their grants for the duration of the disruption caused by the COVID-19 outbreak, the Guardian reports.

Squid can make edits to their RNA within the cytoplasm of their axons, Science News reports.

The Chan Zuckerberg Initiative is putting $25 million toward COVID-19 treatment research, according to the Verge.

In Science this week: researchers engineer version of Cas9 that is nearly PAM-less, and more.